ILMN

#521
Illumina, Inc. - Common Stock
159.5 7 USD
+0.55%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
158.10
160.91
Range Annuel
78.80
160.91
Changement quotidien
+0.55%
Changement Mensuel
+30.55%
Evolution sur 6 mois
+22.86%
Changement Annuel
+91.19%
Clôture Précédente
158.7 0
Open
159.9 6
Low
158.1 0
High
160.9 1
Volume
482
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques
Trimestriel Annuel
  • Market Capitalization 24.14 B
  • Employee 8 650
  • Founded 1998
  • CEO Jacob Thaysen
  • Website www.illumina.com
  • Headquarter Delaware, United States
  • FIGI BBG000DSMS70
  • Industry Diagnostic et Recherche
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
24.68
ratio cours/chiffre d'affaires
4.83

Illumina, Inc. - Common Stock

Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets, and serves more than 155 countries. Illumina's customers include genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, and biotechnology companies.

Nouvelles